Skip to Navigation Skip to Content

We are thrilled to be awarded the Soiree For A Cure grant for the second time in two years in support of the Ian Frazer Centre for Children’s Immunotherapy Research.

The $200,000 contribution from Soiree For A Cure as part of Tour de Cure will help the Ian Frazer Centre continue to look further, dream bigger and change the way our children – and our children’s children – are treated for cancer.

Children’s Hospital Foundation CEO, Lyndsey Rice is incredibly grateful for the continued support of Soiree For A Cure.

“We are incredibly proud of the work at the Ian Frazer Centre for Children’s Immunotherapy Research and the important role our philanthropic partners like Soiree For A Cure play in the way we can approach cancer diagnosis and prognosis,” Ms Rice said.

The Ian Frazer Centre aims to be the first in Australia to develop and deliver clinical trials of novel cancer vaccines using mRNA technology.

The Personal Immunity-Guided Cancer Vaccine (PIC-Vac) project looks to harness recent advances in immunology to boost a child’s own immune response to identify and destroy cancer cells – whilst sparing healthy tissue.

The project has life changing consequences for the 776 children aged 0 – 14 years diagnosed with cancer in Australia each year.

Dr Joseph Yunis is lead researcher on the PIC-Vac clinical trial. He says the hospitality, generosity and educational opportunity shown by ordinary Australians has empowered him to make an impact in his now adopted country.

“Philanthropy is essential to keeping people – like myself – on the task of trying to find a solution to a problem which we think can be solved,” Dr Yunis said.

“Through the generosity of philanthropic institutions and partners like Soiree For A Cure, research is possible.

“Philanthropy not only gives hope to children, but gives hope to the scientists that are always there – day and night – trying to work in the lab, trying to find a solution,” he added.

Head here to find out more on the life changing work of Dr Yunis and the team at the Ian Frazer Centre for Children’s Immunotherapy Research.